LINEAGE CELL THERAPEUTICS IN (LCTX) — institutional ownership

145 funds reported holding LINEAGE CELL THERAPEUTICS IN in their latest 13F filings, worth $168M in total (CUSIP 53566P109).

Largest holders

1. BROADWOOD CAPITAL INC — $64.9M
2. BlackRock, Inc. (BLK) — $17.3M
3. VANGUARD GROUP INC — $16.1M
4. VANGUARD CAPITAL MANAGEMENT LLC — $11.9M
5. COMERICA BANK — $7.68M
6. GEODE CAPITAL MANAGEMENT, LLC — $6.94M
7. Defender Capital, LLC. — $6.35M
8. FIFTH THIRD BANCORP (FITB, FITBI, FITBO, FITBP) — $6.03M
9. MILLENNIUM MANAGEMENT LLC — $3.95M
10. STATE STREET CORP (STT, STT-PG) — $3.03M

Famous investors holding it

• Izzy Englander portfolio (Millennium Management)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Ken Griffin portfolio (Citadel Advisors)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at LINEAGE CELL THERAPEUTICS IN

Who owns the most LCTX stock?

The largest institutional holders in the latest 13F filings are BROADWOOD CAPITAL INC ($64.9M), BlackRock, Inc. (BLK) ($17.3M), VANGUARD GROUP INC ($16.1M).

How many funds own LCTX?

145 funds reported holding it, worth $168M in total.